| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -0.44% | +1.35% | -1.79% | -2.16% | — |
| 14d | 4 | +50.00% | +2.04% | +2.40% | -0.36% | -0.07% | — |
| 30d | 4 | +25.00% | +9.73% | +1.72% | +8.01% | +8.95% | — |
| 60d | 4 | +50.00% | +17.71% | +4.98% | +12.72% | +12.45% | — |
| 90d | 4 | +50.00% | +1.94% | +6.69% | -4.75% | -4.86% | — |
| 180d | 4 | +100.00% | -22.37% | +4.93% | -27.30% | -26.87% | — |
| 1y | 4 | +100.00% | -38.67% | +15.62% | -54.30% | -53.93% | — |
| 2y | 4(2 pending) | +100.00% | -90.78% | +34.59% | -125.37% | -125.37% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 315,750 | — | — | 315,750 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 280,000 | — | — | 280,000 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 105,250 | — | — | 105,250 | Feb 1, 2026 | Feb 2, 2026 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 262,000 | — | — | 262,000 | Jan 25, 2025 | Jan 28, 2025 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Financial Officer | 19,158 | $4.22 | $80.9K | 89,285 | Sep 13, 2024 | Sep 16, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Financial Officer | 9,128 | $4.47 | $40.8K | 108,443 | Sep 12, 2024 | Sep 16, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Financial Officer | 60,000 | — | — | 0 | Sep 11, 2024 | Sep 13, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Financial Officer | 60,000 | — | — | 117,571 | Sep 11, 2024 | Sep 13, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Financial Officer | 29,439 | $3.39 | $99.9K | 57,571 | Jun 26, 2024 | Jun 27, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | SALE Chief Financial Officer | 12,990 | $3.69 | $48.0K | 87,010 | Jun 25, 2024 | Jun 27, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Financial Officer | 90,000 | — | — | 60,000 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASE Chief Financial Officer | 90,000 | — | — | 100,000 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| MREO MEREO BIOPHARMA GROUP PLC | PURCHASEGRANT Stock grant | 245,000 | — | — | 245,000 | Jan 25, 2024 | Jan 26, 2024 ↗ | View → |